Cargando…
Mortality Benefit of a Fourth-Generation Synchronous Telehealth Program for the Management of Chronic Cardiovascular Disease: A Longitudinal Study
BACKGROUND: We have shown that a fourth-generation telehealth program that analyzes and responds synchronously to data transferred from patients is associated with fewer hospitalizations and lower medical costs. Whether a fourth-generation telehealth program can reduce all-cause mortality has not ye...
Autores principales: | Hung, Chi-Sheng, Yu, Jiun-Yu, Lin, Yen-Hung, Chen, Ying-Hsien, Huang, Ching-Chang, Lee, Jen-Kuang, Chuang, Pao-Yu, Ho, Yi-Lwun, Chen, Ming-Fong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909389/ https://www.ncbi.nlm.nih.gov/pubmed/27177497 http://dx.doi.org/10.2196/jmir.5718 |
Ejemplares similares
-
The Costs and Cardiovascular Benefits in Patients With Peripheral Artery Disease From a Fourth-Generation Synchronous Telehealth Program: Retrospective Cohort Study
por: Lee, Jen-Kuang, et al.
Publicado: (2021) -
Assessment of the Cost-Effectiveness and Clinical Outcomes of a Fourth-Generation Synchronous Telehealth Program for the Management of Chronic Cardiovascular Disease
por: Ho, Yi-Lwun, et al.
Publicado: (2014) -
Use of the CHA2DS2-VASc Score for Risk Stratification of Hospital Admissions Among Patients With Cardiovascular Diseases Receiving a Fourth-Generation Synchronous Telehealth Program: Retrospective Cohort Study
por: Lee, Jen-Kuang, et al.
Publicado: (2019) -
Clinical Outcome and Cost-Effectiveness of a Synchronous Telehealth Service for Seniors and Nonseniors with Cardiovascular Diseases: Quasi-Experimental Study
por: Chen, Ying-Hsien, et al.
Publicado: (2013) -
The Impact of Synchronous Telehealth Services With a Digital Platform on Day-by-Day Home Blood Pressure Variability in Patients with Cardiovascular Diseases: Retrospective Cohort Study
por: Chen, Ying-Hsien, et al.
Publicado: (2022)